|
Antimicrobial agent, n(%)
|
|
Ampicillin
|
58 (17.8%)
|
|
Cloxacillin
|
55 (16.9%)
|
|
Metronidazole
|
53 (16.3%)
|
|
Gentamicin
|
39 (12.0%)
|
|
Benzylpenicillin
|
31 (9.5%)
|
|
Ceftriaxone
|
17 (5.2%)
|
|
Other
|
72 (22.2%)
|
|
Route of administration, n(%)
|
|
Parenteral
|
235 (72.3)
|
|
Enteral
|
89 (27.4)
|
|
Other
|
1 (0.3)
|
|
Indication, n(%)
|
|
Treatment of community acquired infection
|
149 (45.8)
|
|
Surgical prophylaxis
|
76 (23.4)
|
|
0–1 day duration
|
31 (40.8)
|
|
> 1 day duration
|
45 (59.2)
|
|
Treatment of healthcare associated infection
|
53 (16.3)
|
|
Medical prophylaxis
|
23 (7.1)
|
|
Unknown
|
16 (4.9)
|
|
Other
|
8 (2.5)
|
|
Length of antimicrobials prior to PPS, median (IQR)
|
|
Overall
|
2 days (1–4)
|
|
ICU/Burns wards
|
3 days (2–5)
|
|
Other wards
|
2 days (1–4)
|
